SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Horizon Therapeutics Reaffirms FY19 Sales Guidance $1.28B-$1.3B vs $1.28B Estimate, Raises Adj. EBITDA Guidance To $465M-$475M

Benzinga · -